Injective (INJ) resold above $5 as the token attempted to extend its recovery from June lows, with buyers now facing resistance around the $5.20 region.
The latest price action comes as Injective filed its transfer agent registration with the U.S. Securities and Exchange Commission (SEC). This is part of the blockchain network’s efforts to integrate real-world assets (RWA) and regulated securities infrastructure on-chain.
Injective Files for SEC Transfer Agent Registration
Injective announced on July 16 that it had officially filed its transfer agent registration with the SEC.
Transfer agents maintain official records of ownership of securities and make changes when those assets change hands. Injective wants to bring this function on-chain, allowing ownership registration to exist on the same blockchain as tokenized security rather than relying on a separate off-chain database.
According to Injective, moving the transfer agent function on-chain could allow market participants to register and transfer ownership of tokenized securities in seconds while reducing the need for multiple intermediaries to reconcile transactions.
The filing begins the registration process and should not be construed as an SEC approval or confirmation that Injective is already operating as a registered transfer agent.
Regulatory push extends beyond the United States
The SEC filing is part of Injective’s broader efforts to expand its regulated financial infrastructure.
Injective said the announcement came hours after the release of its MiCAR white paper, which the project says will support its expansion into European Union member states within the region’s regulatory framework.
Together, these developments highlight Injective’s efforts to position its blockchain infrastructure for institutional and regulated markets in the United States and Europe.
However, the developments have yet to trigger a decisive breakout for INJ.
Can INJ rise above $5.20?
At press time, INJ was trading at around $5.05with the last 12 hours the candle is gaining ground 2.5%.
The token has recovered significantly since its fall around $4.10 end of June. However, price action throughout July remained largely within a consolidation range between approximately $4.50 and $5.20.
The relative strength index (RSI) stood at 56.20above neutral 50 level, suggesting that buying momentum had strengthened. However, the indicator remained well below overbought territory, leaving room for further upside if demand increases.
The immediate challenge is $5.20 region, which repeatedly limited INJ’s recovery attempts during the month of July. A decisive move above this area could signal a break from the recent consolidation range and strengthen the case for an extended recovery.
However, failure to overcome resistance could leave INJ range-bound and expose the token to another test of support around the lower end of its recent trading range.
Final summary
- Injective has filed an application for transfer agent registration with the SEC to bring official ownership records of tokenized securities on-chain.
- INJ recovered above $5 with its RSI rising to 56.20. Nonetheless, the token must overcome resistance around $5.20 to confirm a breakout from its July consolidation range.
